A critical discovery in cancer research is occurring with the use of nanobodies to restore damaged p53. This essential malignant inhibitor protein is frequently inactivated in several forms of tumors, causing https://sites2000.com/story11814730/mini-antibodies-reactivate-p53-new-new-approach-for-tumor-therapy